Cargando…

Mortality in neuromyelitis optica is strongly associated with African ancestry

Detalles Bibliográficos
Autores principales:	Mealy, Maureen A., Kessler, Remi A., Rimler, Zoe, Reid, Allyson, Totonis, Lauren, Cutter, Gary, Kister, Ilya, Levy, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994702/ https://www.ncbi.nlm.nih.gov/pubmed/29892608 http://dx.doi.org/10.1212/NXI.0000000000000468

Ejemplares similares

Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder
por: Kessler, Remi A., et al.
Publicado: (2016)

Disease exacerbation after rituximab induction in neuromyelitis optica
por: Perumal, Jai S., et al.
Publicado: (2015)

Purified human C1-esterase inhibitor is safe in acute relapses of neuromyelitis optica
por: Levy, Michael, et al.
Publicado: (2014)

B-Cell Targeted Treatments for Neuromyelitis Optica Spectrum Disorder: A Focus on CD19 and CD20
por: Levy, Michael, et al.
Publicado: (2021)

A pilot safety study of ublituximab, a monoclonal antibody against CD20, in acute relapses of neuromyelitis optica spectrum disorder
por: Mealy, Maureen A., et al.
Publicado: (2019)

Symptomatic and restorative therapies in neuromyelitis optica spectrum disorders
por: Abboud, Hesham, et al.
Publicado: (2021)

Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder
por: Chavarro, Velina S., et al.
Publicado: (2016)

Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica
por: Kister, Ilya, et al.
Publicado: (2013)

Rituximab during pregnancy in neuromyelitis optica: A case report
por: Miranda-Acuña, Jahir, et al.
Publicado: (2019)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
por: Schanda, Kathrin, et al.
Publicado: (2015)

Longitudinally extensive myelitis in MS mimicking neuromyelitis optica
por: Whittam, Daniel, et al.
Publicado: (2017)

Updated diagnostic criteria for neuromyelitis optica spectrum disorder: Similar outcomes of previously separate cohorts
por: McCreary, M, et al.
Publicado: (2018)

European Ancestry Predominates in Neuromyelitis Optica and Multiple Sclerosis Patients from Brazil
por: Brum, Doralina Guimarães, et al.
Publicado: (2013)

Periventricular Lesions Help Differentiate Neuromyelitis Optica Spectrum Disorders from Multiple Sclerosis
por: Raz, Eytan, et al.
Publicado: (2014)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Retinal Optical Coherence Tomography in Neuromyelitis Optica
por: Oertel, Frederike Cosima, et al.
Publicado: (2021)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Native American ancestry significantly contributes to neuromyelitis optica susceptibility in the admixed Mexican population
por: Romero-Hidalgo, Sandra, et al.
Publicado: (2020)

Neuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto disease
por: Kaku, Michelle, et al.
Publicado: (2016)

Neuromyelitis optica phenotype associated with therapy-responsive acute peripheral neuropathy
por: Feyissa, Anteneh M., et al.
Publicado: (2015)

Ruxolitinib treatment in a patient with neuromyelitis optica: A case report
por: Hodecker, Sibylle C., et al.
Publicado: (2017)

Female hormonal exposures and neuromyelitis optica symptom onset in a multicenter study
por: Bove, Riley, et al.
Publicado: (2017)

Neuromyelitis optica pathogenesis and aquaporin 4
por: Graber, David J, et al.
Publicado: (2008)

MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T
por: Sinnecker, Tim, et al.
Publicado: (2016)

Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

Evidence for classic complement activity in neuromyelitis optica
por: Jones, Melina V., et al.
Publicado: (2014)

Correlation between Amerindian ancestry and neuromyelitis optica spectrum disorders (NMSOD) among patients in Midwestern Brazil
por: Alves, Claudia Soares, et al.
Publicado: (2022)

Plasmapheresis for acute attacks in neuromyelitis optica spectrum disorders
por: Levy, Michael
Publicado: (2018)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico
por: Zarei, Sara, et al.
Publicado: (2018)

Placebo-controlled study in neuromyelitis optica—Ethical and design considerations
por: Cree, Bruce AC, et al.
Publicado: (2015)

New Insights into Neuromyelitis Optica
por: Kim, Woojun, et al.
Publicado: (2011)

Experimental Models of Neuromyelitis Optica
por: Bradl, Monika, et al.
Publicado: (2013)

Molecular Pathogenesis of Neuromyelitis Optica
por: Bukhari, Wajih, et al.
Publicado: (2012)

B lymphocytes in neuromyelitis optica
por: Bennett, Jeffrey L., et al.
Publicado: (2015)

Multisystem involvement in neuromyelitis optica
por: Langille, Megan M., et al.
Publicado: (2015)

A Case of Neuromyelitis Optica
por: DE, M. N., et al.
Publicado: (1946)

Cannot write session to /tmp/vufind_sessions/sess_l4s1peiggfrrf85i1sh7fb9qkq